{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:00:35Z","timestamp":1788908435486,"version":"build-2803163510"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Lecanemab, a monoclonal antibody targeting soluble amyloid-\u03b2 protofibrils, has demonstrated efficacy in reducing amyloid burden in patients with mild cognitive impairment (MCI). However, its effects on brain structure, cerebral perfusion, gray matter microstructure and white matter microstructure remain unclear.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This exploratory longitudinal study aimed to evaluate changes in brain volume, cerebral blood flow (CBF), and diffusion tensor imaging (DTI) measures over a 12-month treatment period in 8 patients with MCI receiving biweekly lecanemab infusions. MRI scans were acquired at baseline and at 6, 9, and 12\u202fmonths using three-dimensional T1-weighted, pseudo-continuous arterial spin labeling (pCASL), and DTI sequences. Changes in whole-brain and regional indices were assessed using the Wilcoxon signed-rank test.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Compared to baseline, brain volume showed significant reductions at all follow-up points across all examined regions, including the whole brain, hippocampus, posterior cingulate cortex, and precuneus. CBF remained stable throughout the observation period in both global and regional analyses. Both fractional anisotropy (FA) and mean diffusivity (MD) showed significant deterioration at the whole-brain level. However, in the hippocampus, left precuneus and cingulum (cingulate gyrus), MD increased significantly at several timepoints, whereas FA remained relatively preserved, suggesting localized preservation of microstructural integrity. Neuropsychological test scores remained stable over time, with no significant deterioration observed across MMSE-J, MoCA-J, CDR-SB, or ADAS-J Cog scores. In parallel, cerebrospinal fluid biomarkers showed significant improvements in A\u03b242, A\u03b242\/40 ratio, and p-tau181 at 6 and 12\u202fmonths.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>These findings suggest that lecanemab may help maintain cerebral perfusion and partially preserve gray matter microstructure and white matter integrity during the early course of treatment in patients with MCI, despite concurrent volumetric and microstructural changes. Multimodal MRI may contribute to monitoring treatment response in patients with MCI receiving lecanemab.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnagi.2025.1651596","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T05:28:44Z","timestamp":1756186124000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Longitudinal multimodal MRI analysis of lecanemab treatment in mild cognitive impairment: a pilot study of structural, perfusion, and microstructural changes"],"prefix":"10.3389","volume":"17","author":[{"given":"Toshiya","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinh Ha Duy","family":"Thuy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Takenaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Asada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Niimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaku","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenao","family":"Fukuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.nurt.2007.05.011","article-title":"Diffusion tensor imaging of the brain","volume":"4","author":"Alexander","year":"2007","journal-title":"Neurotherapeutics"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"871","DOI":"10.3233\/jad-2010-091699","article-title":"Arterial spin labeling blood flow MRI: its role in the early characterization of Alzheimer\u2019s disease","volume":"20","author":"Alsop","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/mrm.25197","article-title":"Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: a consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia","volume":"73","author":"Alsop","year":"2015","journal-title":"Magn. Reson. Med."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.neuroscience.2014.02.017","article-title":"Diffusion tensor imaging of white matter degeneration in Alzheimer\u2019s disease and mild cognitive impairment","volume":"276","author":"Amlien","year":"2014","journal-title":"Neuroscience"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.neuroimage.2017.12.040","article-title":"Susceptibility-induced distortion that varies due to motion: correction in diffusion MR without acquiring additional data","volume":"171","author":"Andersson","year":"2018","journal-title":"NeuroImage"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.neuroimage.2017.02.085","article-title":"Towards a comprehensive framework for movement and distortion correction of diffusion MR images: within volume movement","volume":"152","author":"Andersson","year":"2017","journal-title":"NeuroImage"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.neuroimage.2016.06.058","article-title":"Incorporating outlier detection and replacement into a non-parametric framework for movement and distortion correction of diffusion MR images","volume":"141","author":"Andersson","year":"2016","journal-title":"NeuroImage"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/S1053-8119(03)00336-7","article-title":"How to correct susceptibility distortions in spin-echo echo-planar images: application to diffusion tensor imaging","volume":"20","author":"Andersson","year":"2003","journal-title":"NeuroImage"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.neuroimage.2015.10.019","article-title":"An integrated approach to correction for off-resonance effects and subject movement in diffusion MR imaging","volume":"125","author":"Andersson","year":"2016","journal-title":"NeuroImage"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1007\/s00330-015-3834-9","article-title":"Cerebral perfusion in the predementia stages of Alzheimer\u2019s disease","volume":"26","author":"Binnewijzend","year":"2016","journal-title":"Eur. Radiol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1017\/s135561771700100x","article-title":"Alzheimer\u2019s disease: past, present, and future","volume":"23","author":"Bondi","year":"2017","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"7709","DOI":"10.1523\/jneurosci.2177-05.2005","article-title":"Molecular, structural, and functional characterization of Alzheimer\u2019s disease: evidence for a relationship between default activity, amyloid, and memory","volume":"25","author":"Buckner","year":"2005","journal-title":"J. Neurosci."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1109\/TSP.2008.2005752","article-title":"Variational Bayesian inference for a nonlinear forward model","volume":"57","author":"Chappell","year":"2009","journal-title":"IEEE Trans. Signal Process."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"101911","DOI":"10.1016\/j.arr.2023.101911","article-title":"Abnormal white matter changes in Alzheimer\u2019s disease based on diffusion tensor imaging: a systematic review","volume":"87","author":"Chen","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e12124","DOI":"10.1002\/dad2.12124","article-title":"White matter microstructure disruption in early stage amyloid pathology","volume":"13","author":"Collij","year":"2021","journal-title":"Alzheimers Dement."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.jalz.2015.12.005","article-title":"Meta-analysis of synaptic pathology in Alzheimer\u2019s disease reveals selective molecular vesicular machinery vulnerability","volume":"12","author":"De Wilde","year":"2016","journal-title":"Alzheimers Dement."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"102146","DOI":"10.1016\/j.nicl.2019.102146","article-title":"Arterial spin labeling versus 18F-FDG-PET to identify mild cognitive impairment","volume":"25","author":"Dolui","year":"2020","journal-title":"NeuroImage Clin."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/0197-4580(96)00005-X","article-title":"Topography of brain atrophy during normal aging and Alzheimer\u2019s disease","volume":"17","author":"Double","year":"1996","journal-title":"Neurobiol. Aging"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/s0896-6273(02)00569-x","article-title":"Whole brain segmentation","volume":"33","author":"Fischl","year":"2002","journal-title":"Neuron"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nrneurol.2009.215","article-title":"The clinical use of structural MRI in Alzheimer disease","volume":"6","author":"Frisoni","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1002\/hbm.25369","article-title":"Diagnostic power of resting-state fMRI for detection of network connectivity in Alzheimer\u2019s disease and mild cognitive impairment: a systematic review","volume":"42","author":"Ibrahim","year":"2021","journal-title":"Hum. Brain Mapp."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jneumeth.2016.03.001","article-title":"The first step for neuroimaging data analysis: DICOM to NIfTI conversion","volume":"264","author":"Li","year":"2016","journal-title":"J. Neurosci. Methods"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.nicl.2013.07.006","article-title":"Effectiveness of regional DTI measures in distinguishing Alzheimer\u2019s disease, MCI, and normal aging","volume":"3","author":"Nir","year":"2013","journal-title":"NeuroImage Clin."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1205838","DOI":"10.3389\/fnagi.2023.1205838","article-title":"The correlation between changes in gray matter microstructure and cerebral blood flow in Alzheimer\u2019s disease","volume":"15","author":"Niu","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e16049","DOI":"10.1111\/ene.16049","article-title":"Anti-amyloid antibody treatments for Alzheimer\u2019s disease","volume":"31","author":"Perneczky","year":"2024","journal-title":"Eur. J. Neurol."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"S208","DOI":"10.1016\/j.neuroimage.2004.07.051","article-title":"Advances in functional and structural MR image analysis and implementation as FSL","volume":"23","author":"Smith","year":"2004","journal-title":"NeuroImage"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13195-021-00813-8","article-title":"A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer\u2019s disease with lecanemab, an anti-a\u03b2 protofibril antibody","volume":"13","author":"Swanson","year":"2021","journal-title":"Alzheimers Res Ther"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/nejmoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/13543784.2023.2178414","article-title":"Lecanemab (BAN2401): an anti-beta-amyloid monoclonal antibody for the treatment of Alzheimer disease","volume":"32","author":"Vitek","year":"2023","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.1016\/j.jalz.2012.11.010","article-title":"Vascular alterations in PDAPP mice after anti-a\u03b2 immunotherapy: implications for amyloid-related imaging abnormalities","volume":"9","author":"Zago","year":"2013","journal-title":"Alzheimers Dement."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2025.1651596\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T05:28:45Z","timestamp":1756186125000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2025.1651596\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":31,"alternative-id":["10.3389\/fnagi.2025.1651596"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2025.1651596","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"article-number":"1651596"}}